Gwynfor Owen Humphreys
Keine laufenden Positionen mehr
Karriereverlauf von Gwynfor Owen Humphreys
Ehemalige bekannte Positionen von Gwynfor Owen Humphreys
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AVACTA GROUP PLC | Direktor/Vorstandsmitglied | 13.07.2006 | 23.01.2015 |
| Vorsitzender | 24.12.2010 | 24.01.2014 | |
| GUNSYND PLC | Direktor/Vorstandsmitglied | 01.10.2004 | 15.09.2014 |
| Vorstandsvorsitzender | 03.05.2012 | 15.09.2014 | |
Nektar Therapeutics UK Ltd.
 Nektar Therapeutics UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Nektar Therapeutics, Nektar Therapeutics UK Ltd. develops and manages the exploitation of patented technology for controlled particle formation. The company is based in Bradford, UK. Nektar Therapeutics was acquired by Nektar Therapeutics on January 09, 2001 for $140.98 million. The British company was founded by Mazen Hanna, Gwynfor Owen Humphreys. | Gründer | 01.12.1995 | 01.01.2001 |
| Präsident | 01.12.1995 | 01.01.2001 | |
SolAeroMed, Inc.
 SolAeroMed, Inc. Pharmaceuticals: MajorHealth Technology SolAeroMed, Inc. develops biophysical respiratory drugs and delivery devices for asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). The company was founded by John Butt and Green Francis in 1995 and is headquartered in Calgary, Canada. | Direktor/Vorstandsmitglied | - | - |
Statistik
International
| Vereinigtes Königreich | 4 |
| Kanada | 2 |
Operativ
| Director/Board Member | 3 |
| Chairman | 1 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 4 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AVACTA GROUP PLC | Commercial Services |
| GUNSYND PLC | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Nektar Therapeutics UK Ltd.
Nektar Therapeutics UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Nektar Therapeutics, Nektar Therapeutics UK Ltd. develops and manages the exploitation of patented technology for controlled particle formation. The company is based in Bradford, UK. Nektar Therapeutics was acquired by Nektar Therapeutics on January 09, 2001 for $140.98 million. The British company was founded by Mazen Hanna, Gwynfor Owen Humphreys. | Health Technology |
SolAeroMed, Inc.
SolAeroMed, Inc. Pharmaceuticals: MajorHealth Technology SolAeroMed, Inc. develops biophysical respiratory drugs and delivery devices for asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). The company was founded by John Butt and Green Francis in 1995 and is headquartered in Calgary, Canada. | Health Technology |
- Börse
- Insiders
- Gwynfor Owen Humphreys
- Erfahrung
